Covance LabCorp Expands Companion Dx Agreement With BML The agreement will initially focus on making available assays developed and validated by LabCorp's Covance business, with the first assays targeting oncology. NanoString Partners With CROs to Expand Access to Cancer Research Panel The deals with Covance, NeoGenomics Laboratories, and Navigate BioPharma Services aim to expand access to NanoString's PanCancer IO 360 Gene Expression Panel. Biocartis, Covance Sign Commercialization Agreement for Idylla Idylla molecular testing instruments will be placed at Covance sites to support customer needs for clinical trials and to validate and implement companion diagnostic applications. Mission Bio, LabCorp Collaborate on Clinical Trials, Companion Dx Development LabCorp's Covance business plans to offer single-cell services on Mission Bio's platform to pharma and to explore its use in companion diagnostics. LabCorp Q2 Revenues Rise 5 Percent, Fueled by Diagnostics Growth Total revenues reached $2.54 billion during the quarter, while LabCorp Diagnostics' revenues rose more than 8 percent to $1.80 billion. Jul 20, 2017 LabCorp's Covance Sees Place for Itself in New Drug-Dx Codevelopment Landscape Oct 26, 2015 LabCorp Reports Continued Boost From Covance Purchase as Q3 Revenues Rise 46 Percent Jul 28, 2015 LabCorp Reports 46 Percent Q2 Revenue Surge from Covance Acquisition Jul 7, 2015 Epic, LabCorp Expand Clinical Trials Pact in Asia Using Covance Capabilities Apr 27, 2015 LabCorp Reports 24 Percent Q1 Revenue Jump on Covance Acquisition Mar 25, 2015 Covance Acquisition Accelerates LabCorp's Stake in CDx Space, CEO Says Jan 23, 2015 LabCorp Prices $2.9B Offering of Senior Notes Nov 3, 2014 LabCorp to Acquire Covance for $6.1B Sep 5, 2014 In Brief This Week: EMD Serono, Massachusetts General Hospital; Rosetta Genomics; BioLegend, Covance Feb 25, 2014 LabCorp Acquires Covance's High-Complexity Genomic Laboratory Nov 18, 2013 Covance, NeoGenomics to Jointly Offer Services for Clinical Trials Nov 5, 2013 Covance and PathoQuest Partner on NGS-based Biosafety Testing Feb 27, 2013 MDx/CDx Focus: Abbott CDx for Janssen, Pharmacyclics' Lymphoma Drug; Covance, M2Gen Collaborate Premium Feb 26, 2013 Covance, M2Gen Aim to Improve Patient Recruitment for Oncology Trials Sep 19, 2012 GNS Healthcare, Covance Team on Data-Driven Personalized Medicine May 9, 2012 International Study Hopes to Identify Genetic Markers to Predict Response to Antidepressants Premium Feb 29, 2012 MedImmune Turns to NGS in Collaboration with Shanghai Chest Hospital to Study Lung Cancer Premium Oct 28, 2011 Movers & Shakers: Oct 28, 2011 Premium Aug 3, 2011 Covance to Collaborate with Broad Institute on microRNA Research Mar 29, 2011 Q&A: Covance's Tom Turi on the Rise of Sequencing in Drug Discovery and Development Premium Load More Breaking News Mainz Biomed to Initiate Pivotal US Clinical Study for Colorectal Cancer Early Detection Test Pacific Biosciences, Boston Children's Hospital to Collaborate on Rare Disease Variant Pilot Project Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Gut Microbiome Characteristics Tied to Depressive Symptoms in New Studies Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients The Scan Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan. Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus. Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities. Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.